Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: MERLIN BIOTECH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-22 to 2026-09-21
Current total value of award: $355000
Description: SBIR FY25 CONCEPT AWARD, DEVELOPMENT OF AN IMMUNOTHERAPY FOR EWING SARCOMA USING A NOVEL MURINE MODEL